Igelmann Sebastian, Lessard Frédéric, Ferbeyre Gerardo
Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC H3C 3J7, Canada.
Montreal Cancer Institute, CR-CHUM, Université de Montréal, Montréal, QC H2X 0A9, Canada.
Cancers (Basel). 2022 Apr 5;14(7):1830. doi: 10.3390/cancers14071830.
The cancer state is thought to be maintained by genetic and epigenetic changes that drive a cancer-promoting gene expression program. However, recent results show that cellular states can be also stably maintained by the reorganization of cell structure leading to the formation of biological condensates via the process of liquid-liquid phase separation. Here, we review the data showing cancer-specific biological condensates initiated by mutant oncoproteins, RNA-binding proteins, or lincRNAs that regulate oncogenic gene expression programs and cancer metabolism. Effective anticancer drugs may specifically partition into oncogenic biological condensates (OBC).
癌症状态被认为是由驱动促癌基因表达程序的遗传和表观遗传变化所维持。然而,最近的研究结果表明,细胞状态也可以通过细胞结构的重组来稳定维持,这种重组通过液-液相分离过程导致生物凝聚物的形成。在这里,我们回顾了相关数据,这些数据显示了由调节致癌基因表达程序和癌症代谢的突变癌蛋白、RNA结合蛋白或长链非编码RNA引发的癌症特异性生物凝聚物。有效的抗癌药物可能会特异性地分配到致癌生物凝聚物(OBC)中。